Louisssss personal page - To The Moon

Louisssss

No personal profile

38Follow

0Followers

0Topic

0Badge

2021-06-29

Hello

Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away

2021-06-29

Nice update

Tech stock rally sends S&P and Nasdaq to record highs

2021-06-29

Good

Tech stock rally sends S&P and Nasdaq to record highs

2021-06-29

Nice

UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light

2021-06-29

Nice

UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light

2021-06-10

Nice

Company spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit

2021-06-10

Great

Baird says GameStop's turnaround plan remains a mystery, predicts 90% stock decline

2021-06-10

Nice

Sorry, the original content has been removed

2021-06-09

Good buy

2021-05-08

Good

Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues

2021-05-08

Good

WHO approves Covid vaccine made by China's Sinopharm for emergency use

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3581648312409141,"uuid":"3581648312409141","gmtCreate":1618937870063,"gmtModify":1618937870063,"name":"Louisssss","pinyin":"louisssss","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":38,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":159342994,"gmtCreate":1624943960018,"gmtModify":1703848548141,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Hello","listText":"Hello","text":"Hello","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159342994","repostId":"2147449837","repostType":2,"repost":{"id":"2147449837","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1624916160,"share":"https://ttm.financial/m/news/2147449837?lang=&edition=fundamental","pubTime":"2021-06-29 05:36","market":"hk","language":"en","title":"Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away","url":"https://stock-news.laohu8.com/highlight/detail?id=2147449837","media":"Dow Jones","summary":"MW Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccinatio","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away\n</p>\n<p>\n  Jaimy LeeJillian BermanAndrew Keshner \n</p>\n<p>\n  Upgrade from emergency-use authorizations could open the door to vaccine mandates from more employers -- including the U.S. military -- and schools \n</p>\n<p>\n  The \"full\" approval of Pfizer's and Moderna's COVID-19 vaccines will almost certainly boost sagging vaccination rates in the U.S., though the Food and Drug Administration's decision might not come until the end of the year. \n</p>\n<p>\n  The Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and Moderna Inc. <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> vaccines, along with Johnson &amp; Johnson's <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> COVID-19 shot, have received emergency-use authorization, a less rigorous category of approval granted by the FDA that allowed the vaccines to be distributed more quickly during a critical stage of the public health emergency. \n</p>\n<p>\n  Though an FDA decision isn't required until the end of the year, people are already evaluating how a formal approval would impact lagging vaccination rates in the U.S. amid a murky landscape for required immunization in the U.S. \n</p>\n<p>\n  More than 153 million people in the U.S., or roughly 46% of the total population, have voluntarily chosen to get vaccinated, according to data  from the Centers for Disease Control and Prevention. \n</p>\n<p>\n  But a recent slowdown  \n</p>\n<p>\n  All signs point to a boost, whatever its magnitude, in the ongoing COVID-19 vaccination campaign in the U.S. if and when the vaccines are formally approved. \n</p>\n<p>\n  Approval will allow drug manufacturers to advertise their vaccines and, in some cases, set their own prices. It may also mean that employers and schools will have an established legal precedent to require vaccination, and it could tip people in the wait-and-see category to get vaccinated once they know the vaccines have gone through a more rigorous regulatory screening. \n</p>\n<p>\n  \"A third of people who are unvaccinated said that they'd be more likely to get the vaccine if ... <a href=\"https://laohu8.com/S/AONE\">one</a> of the vaccines received full approval from the FDA,\" said Liz Hamel, director of public opinion and survey research at the Henry J. Kaiser Family Foundation, which has studied COVID-19 vaccine hesitancy. \n</p>\n<p>\n  A full FDA approval could help the lagging vaccination rate in the U.S. \n</p>\n<p>\n  About 12% of unvaccinated people in the U.S. are part of the wait-and-see group, according to the Kaiser Family Foundation. They tend to be young adults and Black adults. \n</p>\n<p>\n  For some people, approval sounds safer than emergency authorization. \"We hear people say, it's just experimental at this point. It's not approved yet,\" Hamel said. \"They hear terms like 'emergency,' and then they are just still cautious.\" \n</p>\n<p>\n  Arkansas Gov. Asa Hutchinson said the state needs full approval to combat vaccine hesitancy. \"It was approved as emergency use,\" the Republican told \"Face the Nation\"  this weekend. \"And so, for that reason, you can't mandate it.\" \n</p>\n<p>\n  An FDA approval for a COVID-19 vaccine requires six months of follow-up data from the clinical trial, three times the two months' worth of follow-up data  used to inform emergency authorization. \n</p>\n<p>\n  The regulator has 60 days after the companies submit their applications to decide if it is going to grant \"priority review,\" a designation that requires the federal agency to make a decision whether or not to approve the vaccine within six months. Pfizer said it submitted its application on May 7; Moderna followed, on June 1, with its submission. \n</p>\n<p>\n  Between 6% and 7% of unvaccinated Americans say they'll get a shot only if they are required by an employer or a school, or to travel. While some employers already require vaccinations -- the Houston Methodist hospital system in Texas went to legal lengths  for returning employees -- these kinds of requirements are not the norm. \n</p>\n<p>\n  The U.S. military, with its 1.3 million active-duty members, has not required vaccination but has suggested  he would leave that decision in the hands of the military brass. \n</p>\n<p>\n  \"Some people will respond to incentives, and some will respond to requirements,\" the Kaiser Family Foundation's Hamel said. \n</p>\n<p>\n  We'll see TV ads promoting vaccines. \n</p>\n<p>\n  Right now, drug companies are limited in what they are allowed to say about their vaccines based on the rules of emergency authorization. They can't advertise the vaccines to the public or to prescribers -- or proactively explain the safety and effectiveness of their shots. \n</p>\n<p>\n  \"You essentially have to stick to the script that's in the EUA,\" said Cody Powers, a COVID-19 vaccine expert at ZS, a pharmaceutical consulting firm. \"You can't make explicit claims about safety and effectiveness.\" \n</p>\n<p>\n  If and when FDA approvals are granted, companies like Moderna and Pfizer may stay cautious in their approach to marketing COVID-19 vaccines in the U.S. Traditionally, pharmaceutical companies hold off on putting out direct-to-consumer ads for six months after approval as a result of concerns about aggressive marketing practices. In this case, there likely will be worries about corporate profit motivations during a global pandemic. \n</p>\n<p>\n  \"If they feel like they're jeopardizing both their own perception and the success of overall inoculations in the U.S., they might step back,\" Powers said. \n</p>\n<p>\n  Drug manufacturers usually start with disease-awareness campaigns for new products and then later launch brand campaigns that seek to either raise awareness of their particular offering or to differentiate it. \n</p>\n<p>\n  But this moment in time is very different. The American public already knows about the vaccines and their makers. In fact, many people are well-versed in efficacy rates from the clinical trials and even how the FDA regulatory process works. That means we already have perceptions of each vaccine, whether that's sillier ones, like the TikTok idea that Pfizer's vaccine is for \"hot\" people . \n</p>\n<p>\n  \"When you can make claims about the vaccine, then all the promotional machinery around that claim turns on,\" Powers said. \"It's a really weird situation for most manufacturers, where they're actually having to make decisions about whether to just roll with what they've inherited or try to change people's perceptions.\" \n</p>\n<p>\n  The price of at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> vaccine may eventually go up. \n</p>\n<p>\n  Moderna will also gain more control over the pricing of its vaccine once it is approved, according to remarks made earlier this month by CEO Stéphane Bancel. \n</p>\n<p>\n  The price of Moderna's shot works out to $15 per dose, in comparison with the $19.50 charged by Pfizer , had more price-setting freedom. \n</p>\n<p>\n  With approval, \"we should be able to go into the private market,\" Moderna's Bancel told investors. \"The price is pretty low because at the time the deal was done there was no clinical data.\" -- Jaimy Lee \n</p>\n<p>\n  Colleges are going to lead the way when it comes to requiring vaccines in educational settings. \n</p>\n<p>\n  Hundreds of colleges  in the U.S. have announced vaccine requirements for students and, less often, employees. But full FDA approval is expected to broaden both the number of schools mandating vaccination and the scope of the requirements in place. \n</p>\n<p>\n  The California Institute of Technology said  everyone in its community to get vaccinated. \n</p>\n<p>\n  (MORE TO FOLLOW) Dow Jones Newswires\n</p>\n<p>\n  June 28, 2021 17:36 ET (21:36 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFull FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-29 05:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away\n</p>\n<p>\n  Jaimy LeeJillian BermanAndrew Keshner \n</p>\n<p>\n  Upgrade from emergency-use authorizations could open the door to vaccine mandates from more employers -- including the U.S. military -- and schools \n</p>\n<p>\n  The \"full\" approval of Pfizer's and Moderna's COVID-19 vaccines will almost certainly boost sagging vaccination rates in the U.S., though the Food and Drug Administration's decision might not come until the end of the year. \n</p>\n<p>\n  The Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and Moderna Inc. <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> vaccines, along with Johnson &amp; Johnson's <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> COVID-19 shot, have received emergency-use authorization, a less rigorous category of approval granted by the FDA that allowed the vaccines to be distributed more quickly during a critical stage of the public health emergency. \n</p>\n<p>\n  Though an FDA decision isn't required until the end of the year, people are already evaluating how a formal approval would impact lagging vaccination rates in the U.S. amid a murky landscape for required immunization in the U.S. \n</p>\n<p>\n  More than 153 million people in the U.S., or roughly 46% of the total population, have voluntarily chosen to get vaccinated, according to data  from the Centers for Disease Control and Prevention. \n</p>\n<p>\n  But a recent slowdown  \n</p>\n<p>\n  All signs point to a boost, whatever its magnitude, in the ongoing COVID-19 vaccination campaign in the U.S. if and when the vaccines are formally approved. \n</p>\n<p>\n  Approval will allow drug manufacturers to advertise their vaccines and, in some cases, set their own prices. It may also mean that employers and schools will have an established legal precedent to require vaccination, and it could tip people in the wait-and-see category to get vaccinated once they know the vaccines have gone through a more rigorous regulatory screening. \n</p>\n<p>\n  \"A third of people who are unvaccinated said that they'd be more likely to get the vaccine if ... <a href=\"https://laohu8.com/S/AONE\">one</a> of the vaccines received full approval from the FDA,\" said Liz Hamel, director of public opinion and survey research at the Henry J. Kaiser Family Foundation, which has studied COVID-19 vaccine hesitancy. \n</p>\n<p>\n  A full FDA approval could help the lagging vaccination rate in the U.S. \n</p>\n<p>\n  About 12% of unvaccinated people in the U.S. are part of the wait-and-see group, according to the Kaiser Family Foundation. They tend to be young adults and Black adults. \n</p>\n<p>\n  For some people, approval sounds safer than emergency authorization. \"We hear people say, it's just experimental at this point. It's not approved yet,\" Hamel said. \"They hear terms like 'emergency,' and then they are just still cautious.\" \n</p>\n<p>\n  Arkansas Gov. Asa Hutchinson said the state needs full approval to combat vaccine hesitancy. \"It was approved as emergency use,\" the Republican told \"Face the Nation\"  this weekend. \"And so, for that reason, you can't mandate it.\" \n</p>\n<p>\n  An FDA approval for a COVID-19 vaccine requires six months of follow-up data from the clinical trial, three times the two months' worth of follow-up data  used to inform emergency authorization. \n</p>\n<p>\n  The regulator has 60 days after the companies submit their applications to decide if it is going to grant \"priority review,\" a designation that requires the federal agency to make a decision whether or not to approve the vaccine within six months. Pfizer said it submitted its application on May 7; Moderna followed, on June 1, with its submission. \n</p>\n<p>\n  Between 6% and 7% of unvaccinated Americans say they'll get a shot only if they are required by an employer or a school, or to travel. While some employers already require vaccinations -- the Houston Methodist hospital system in Texas went to legal lengths  for returning employees -- these kinds of requirements are not the norm. \n</p>\n<p>\n  The U.S. military, with its 1.3 million active-duty members, has not required vaccination but has suggested  he would leave that decision in the hands of the military brass. \n</p>\n<p>\n  \"Some people will respond to incentives, and some will respond to requirements,\" the Kaiser Family Foundation's Hamel said. \n</p>\n<p>\n  We'll see TV ads promoting vaccines. \n</p>\n<p>\n  Right now, drug companies are limited in what they are allowed to say about their vaccines based on the rules of emergency authorization. They can't advertise the vaccines to the public or to prescribers -- or proactively explain the safety and effectiveness of their shots. \n</p>\n<p>\n  \"You essentially have to stick to the script that's in the EUA,\" said Cody Powers, a COVID-19 vaccine expert at ZS, a pharmaceutical consulting firm. \"You can't make explicit claims about safety and effectiveness.\" \n</p>\n<p>\n  If and when FDA approvals are granted, companies like Moderna and Pfizer may stay cautious in their approach to marketing COVID-19 vaccines in the U.S. Traditionally, pharmaceutical companies hold off on putting out direct-to-consumer ads for six months after approval as a result of concerns about aggressive marketing practices. In this case, there likely will be worries about corporate profit motivations during a global pandemic. \n</p>\n<p>\n  \"If they feel like they're jeopardizing both their own perception and the success of overall inoculations in the U.S., they might step back,\" Powers said. \n</p>\n<p>\n  Drug manufacturers usually start with disease-awareness campaigns for new products and then later launch brand campaigns that seek to either raise awareness of their particular offering or to differentiate it. \n</p>\n<p>\n  But this moment in time is very different. The American public already knows about the vaccines and their makers. In fact, many people are well-versed in efficacy rates from the clinical trials and even how the FDA regulatory process works. That means we already have perceptions of each vaccine, whether that's sillier ones, like the TikTok idea that Pfizer's vaccine is for \"hot\" people . \n</p>\n<p>\n  \"When you can make claims about the vaccine, then all the promotional machinery around that claim turns on,\" Powers said. \"It's a really weird situation for most manufacturers, where they're actually having to make decisions about whether to just roll with what they've inherited or try to change people's perceptions.\" \n</p>\n<p>\n  The price of at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> vaccine may eventually go up. \n</p>\n<p>\n  Moderna will also gain more control over the pricing of its vaccine once it is approved, according to remarks made earlier this month by CEO Stéphane Bancel. \n</p>\n<p>\n  The price of Moderna's shot works out to $15 per dose, in comparison with the $19.50 charged by Pfizer , had more price-setting freedom. \n</p>\n<p>\n  With approval, \"we should be able to go into the private market,\" Moderna's Bancel told investors. \"The price is pretty low because at the time the deal was done there was no clinical data.\" -- Jaimy Lee \n</p>\n<p>\n  Colleges are going to lead the way when it comes to requiring vaccines in educational settings. \n</p>\n<p>\n  Hundreds of colleges  in the U.S. have announced vaccine requirements for students and, less often, employees. But full FDA approval is expected to broaden both the number of schools mandating vaccination and the scope of the requirements in place. \n</p>\n<p>\n  The California Institute of Technology said  everyone in its community to get vaccinated. \n</p>\n<p>\n  (MORE TO FOLLOW) Dow Jones Newswires\n</p>\n<p>\n  June 28, 2021 17:36 ET (21:36 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","JNJ":"强生"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147449837","content_text":"MW Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away\n\n\n  Jaimy LeeJillian BermanAndrew Keshner \n\n\n  Upgrade from emergency-use authorizations could open the door to vaccine mandates from more employers -- including the U.S. military -- and schools \n\n\n  The \"full\" approval of Pfizer's and Moderna's COVID-19 vaccines will almost certainly boost sagging vaccination rates in the U.S., though the Food and Drug Administration's decision might not come until the end of the year. \n\n\n  The Pfizer Inc. $(PFE)$ and Moderna Inc. $(MRNA)$ vaccines, along with Johnson & Johnson's $(JNJ)$ COVID-19 shot, have received emergency-use authorization, a less rigorous category of approval granted by the FDA that allowed the vaccines to be distributed more quickly during a critical stage of the public health emergency. \n\n\n  Though an FDA decision isn't required until the end of the year, people are already evaluating how a formal approval would impact lagging vaccination rates in the U.S. amid a murky landscape for required immunization in the U.S. \n\n\n  More than 153 million people in the U.S., or roughly 46% of the total population, have voluntarily chosen to get vaccinated, according to data  from the Centers for Disease Control and Prevention. \n\n\n  But a recent slowdown  \n\n\n  All signs point to a boost, whatever its magnitude, in the ongoing COVID-19 vaccination campaign in the U.S. if and when the vaccines are formally approved. \n\n\n  Approval will allow drug manufacturers to advertise their vaccines and, in some cases, set their own prices. It may also mean that employers and schools will have an established legal precedent to require vaccination, and it could tip people in the wait-and-see category to get vaccinated once they know the vaccines have gone through a more rigorous regulatory screening. \n\n\n  \"A third of people who are unvaccinated said that they'd be more likely to get the vaccine if ... one of the vaccines received full approval from the FDA,\" said Liz Hamel, director of public opinion and survey research at the Henry J. Kaiser Family Foundation, which has studied COVID-19 vaccine hesitancy. \n\n\n  A full FDA approval could help the lagging vaccination rate in the U.S. \n\n\n  About 12% of unvaccinated people in the U.S. are part of the wait-and-see group, according to the Kaiser Family Foundation. They tend to be young adults and Black adults. \n\n\n  For some people, approval sounds safer than emergency authorization. \"We hear people say, it's just experimental at this point. It's not approved yet,\" Hamel said. \"They hear terms like 'emergency,' and then they are just still cautious.\" \n\n\n  Arkansas Gov. Asa Hutchinson said the state needs full approval to combat vaccine hesitancy. \"It was approved as emergency use,\" the Republican told \"Face the Nation\"  this weekend. \"And so, for that reason, you can't mandate it.\" \n\n\n  An FDA approval for a COVID-19 vaccine requires six months of follow-up data from the clinical trial, three times the two months' worth of follow-up data  used to inform emergency authorization. \n\n\n  The regulator has 60 days after the companies submit their applications to decide if it is going to grant \"priority review,\" a designation that requires the federal agency to make a decision whether or not to approve the vaccine within six months. Pfizer said it submitted its application on May 7; Moderna followed, on June 1, with its submission. \n\n\n  Between 6% and 7% of unvaccinated Americans say they'll get a shot only if they are required by an employer or a school, or to travel. While some employers already require vaccinations -- the Houston Methodist hospital system in Texas went to legal lengths  for returning employees -- these kinds of requirements are not the norm. \n\n\n  The U.S. military, with its 1.3 million active-duty members, has not required vaccination but has suggested  he would leave that decision in the hands of the military brass. \n\n\n  \"Some people will respond to incentives, and some will respond to requirements,\" the Kaiser Family Foundation's Hamel said. \n\n\n  We'll see TV ads promoting vaccines. \n\n\n  Right now, drug companies are limited in what they are allowed to say about their vaccines based on the rules of emergency authorization. They can't advertise the vaccines to the public or to prescribers -- or proactively explain the safety and effectiveness of their shots. \n\n\n  \"You essentially have to stick to the script that's in the EUA,\" said Cody Powers, a COVID-19 vaccine expert at ZS, a pharmaceutical consulting firm. \"You can't make explicit claims about safety and effectiveness.\" \n\n\n  If and when FDA approvals are granted, companies like Moderna and Pfizer may stay cautious in their approach to marketing COVID-19 vaccines in the U.S. Traditionally, pharmaceutical companies hold off on putting out direct-to-consumer ads for six months after approval as a result of concerns about aggressive marketing practices. In this case, there likely will be worries about corporate profit motivations during a global pandemic. \n\n\n  \"If they feel like they're jeopardizing both their own perception and the success of overall inoculations in the U.S., they might step back,\" Powers said. \n\n\n  Drug manufacturers usually start with disease-awareness campaigns for new products and then later launch brand campaigns that seek to either raise awareness of their particular offering or to differentiate it. \n\n\n  But this moment in time is very different. The American public already knows about the vaccines and their makers. In fact, many people are well-versed in efficacy rates from the clinical trials and even how the FDA regulatory process works. That means we already have perceptions of each vaccine, whether that's sillier ones, like the TikTok idea that Pfizer's vaccine is for \"hot\" people . \n\n\n  \"When you can make claims about the vaccine, then all the promotional machinery around that claim turns on,\" Powers said. \"It's a really weird situation for most manufacturers, where they're actually having to make decisions about whether to just roll with what they've inherited or try to change people's perceptions.\" \n\n\n  The price of at least one vaccine may eventually go up. \n\n\n  Moderna will also gain more control over the pricing of its vaccine once it is approved, according to remarks made earlier this month by CEO Stéphane Bancel. \n\n\n  The price of Moderna's shot works out to $15 per dose, in comparison with the $19.50 charged by Pfizer , had more price-setting freedom. \n\n\n  With approval, \"we should be able to go into the private market,\" Moderna's Bancel told investors. \"The price is pretty low because at the time the deal was done there was no clinical data.\" -- Jaimy Lee \n\n\n  Colleges are going to lead the way when it comes to requiring vaccines in educational settings. \n\n\n  Hundreds of colleges  in the U.S. have announced vaccine requirements for students and, less often, employees. But full FDA approval is expected to broaden both the number of schools mandating vaccination and the scope of the requirements in place. \n\n\n  The California Institute of Technology said  everyone in its community to get vaccinated. \n\n\n  (MORE TO FOLLOW) Dow Jones Newswires\n\n\n  June 28, 2021 17:36 ET (21:36 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":267,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159343286,"gmtCreate":1624943742645,"gmtModify":1703848541337,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice update","listText":"Nice update","text":"Nice update","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159343286","repostId":"2147837316","repostType":2,"repost":{"id":"2147837316","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624921533,"share":"https://ttm.financial/m/news/2147837316?lang=&edition=fundamental","pubTime":"2021-06-29 07:05","market":"us","language":"en","title":"Tech stock rally sends S&P and Nasdaq to record highs","url":"https://stock-news.laohu8.com/highlight/detail?id=2147837316","media":"Reuters","summary":" - The Nasdaq and S&P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&P 500 and the Nasdaq.The S&P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.In contrast, cycl","content":"<p>(Reuters) - The Nasdaq and S&amp;P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.</p>\n<p>Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&amp;P 500 and the Nasdaq.</p>\n<p>The S&amp;P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.</p>\n<p>In contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&amp;P 500, down by 0.81% and 3.33%, respectively.</p>\n<p>“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.</p>\n<p>Stovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&amp;P 500 companies is expected to top 60%.</p>\n<p>The Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&amp;P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.</p>\n<p>Both the S&amp;P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.</p>\n<p>“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.</p>\n<p>Facebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.</p>\n<p>On the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.</p>\n<p>With the S&amp;P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.</p>\n<p>On the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.</p>\n<p>Volume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech stock rally sends S&P and Nasdaq to record highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech stock rally sends S&P and Nasdaq to record highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 07:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Reuters) - The Nasdaq and S&amp;P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.</p>\n<p>Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&amp;P 500 and the Nasdaq.</p>\n<p>The S&amp;P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.</p>\n<p>In contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&amp;P 500, down by 0.81% and 3.33%, respectively.</p>\n<p>“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.</p>\n<p>Stovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&amp;P 500 companies is expected to top 60%.</p>\n<p>The Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&amp;P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.</p>\n<p>Both the S&amp;P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.</p>\n<p>“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.</p>\n<p>Facebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.</p>\n<p>On the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.</p>\n<p>With the S&amp;P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.</p>\n<p>On the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.</p>\n<p>Volume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WBA":"沃尔格林联合博姿","PSQ":"纳指反向ETF","NDAQ":"纳斯达克OMX交易所",".SPX":"S&P 500 Index","TQQQ":"纳指三倍做多ETF","QID":"纳指两倍做空ETF","NVDA":"英伟达","MU":"美光科技",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","NFLX":"奈飞",".DJI":"道琼斯","SQQQ":"纳指三倍做空ETF","TWTR":"Twitter"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147837316","content_text":"(Reuters) - The Nasdaq and S&P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.\nBig tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&P 500 and the Nasdaq.\nThe S&P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.\nIn contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&P 500, down by 0.81% and 3.33%, respectively.\n“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.\nStovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&P 500 companies is expected to top 60%.\nThe Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.\nBoth the S&P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.\n“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.\nFacebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.\nOn the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.\nWith the S&P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.\nOn the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.\nThe S&P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.\nVolume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159349785,"gmtCreate":1624943707847,"gmtModify":1703848540206,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159349785","repostId":"2147837316","repostType":2,"repost":{"id":"2147837316","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624921533,"share":"https://ttm.financial/m/news/2147837316?lang=&edition=fundamental","pubTime":"2021-06-29 07:05","market":"us","language":"en","title":"Tech stock rally sends S&P and Nasdaq to record highs","url":"https://stock-news.laohu8.com/highlight/detail?id=2147837316","media":"Reuters","summary":" - The Nasdaq and S&P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&P 500 and the Nasdaq.The S&P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.In contrast, cycl","content":"<p>(Reuters) - The Nasdaq and S&amp;P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.</p>\n<p>Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&amp;P 500 and the Nasdaq.</p>\n<p>The S&amp;P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.</p>\n<p>In contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&amp;P 500, down by 0.81% and 3.33%, respectively.</p>\n<p>“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.</p>\n<p>Stovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&amp;P 500 companies is expected to top 60%.</p>\n<p>The Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&amp;P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.</p>\n<p>Both the S&amp;P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.</p>\n<p>“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.</p>\n<p>Facebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.</p>\n<p>On the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.</p>\n<p>With the S&amp;P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.</p>\n<p>On the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.</p>\n<p>Volume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech stock rally sends S&P and Nasdaq to record highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech stock rally sends S&P and Nasdaq to record highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 07:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Reuters) - The Nasdaq and S&amp;P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.</p>\n<p>Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&amp;P 500 and the Nasdaq.</p>\n<p>The S&amp;P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.</p>\n<p>In contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&amp;P 500, down by 0.81% and 3.33%, respectively.</p>\n<p>“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.</p>\n<p>Stovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&amp;P 500 companies is expected to top 60%.</p>\n<p>The Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&amp;P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.</p>\n<p>Both the S&amp;P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.</p>\n<p>“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.</p>\n<p>Facebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.</p>\n<p>On the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.</p>\n<p>With the S&amp;P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.</p>\n<p>On the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.</p>\n<p>Volume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WBA":"沃尔格林联合博姿","PSQ":"纳指反向ETF","NDAQ":"纳斯达克OMX交易所",".SPX":"S&P 500 Index","TQQQ":"纳指三倍做多ETF","QID":"纳指两倍做空ETF","NVDA":"英伟达","MU":"美光科技",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","NFLX":"奈飞",".DJI":"道琼斯","SQQQ":"纳指三倍做空ETF","TWTR":"Twitter"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147837316","content_text":"(Reuters) - The Nasdaq and S&P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.\nBig tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&P 500 and the Nasdaq.\nThe S&P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.\nIn contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&P 500, down by 0.81% and 3.33%, respectively.\n“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.\nStovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&P 500 companies is expected to top 60%.\nThe Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.\nBoth the S&P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.\n“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.\nFacebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.\nOn the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.\nWith the S&P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.\nOn the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.\nThe S&P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.\nVolume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159340840,"gmtCreate":1624943653180,"gmtModify":1703848538431,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159340840","repostId":"2147858544","repostType":2,"repost":{"id":"2147858544","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624924843,"share":"https://ttm.financial/m/news/2147858544?lang=&edition=fundamental","pubTime":"2021-06-29 08:00","market":"us","language":"en","title":"UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light","url":"https://stock-news.laohu8.com/highlight/detail?id=2147858544","media":"Reuters","summary":"(Adds Wells Fargo details, executive quotes)   By David Henry and Niket  Nishant   June 28 (Reuters)","content":"<html><body><p>(Adds Wells Fargo details, executive quotes)</p><p>   By David Henry and Niket  Nishant</p><p>   June 28 (Reuters) - <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week. </p><p>   Analysts and investors had expected </p><p>the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.</p><p>   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents. </p><p>   The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.</p><p>   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"</p><p>   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase &amp; Co    said it will go to $1.00 a share from 90 cents for the third quarter. </p><p>   Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25. </p><p>   Wells Fargo &amp; Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September. </p><p>   The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.</p><p>   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.</p><p>   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.</p><p>   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.</p><p>   CITIGROUP</p><p>   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%. </p><p>   A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.</p><p>   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.</p><p>   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.</p><p>   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.</p><p>   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules.</p><p> (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)</p><p>((Niket.Nishant@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 08:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds Wells Fargo details, executive quotes)</p><p>   By David Henry and Niket  Nishant</p><p>   June 28 (Reuters) - <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week. </p><p>   Analysts and investors had expected </p><p>the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.</p><p>   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents. </p><p>   The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.</p><p>   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"</p><p>   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase &amp; Co    said it will go to $1.00 a share from 90 cents for the third quarter. </p><p>   Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25. </p><p>   Wells Fargo &amp; Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September. </p><p>   The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.</p><p>   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.</p><p>   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.</p><p>   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.</p><p>   CITIGROUP</p><p>   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%. </p><p>   A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.</p><p>   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.</p><p>   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.</p><p>   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.</p><p>   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules.</p><p> (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)</p><p>((Niket.Nishant@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛","JPM":"摩根大通","WFC":"富国银行","MS":"摩根士丹利","C":"花旗","BAC":"美国银行"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147858544","content_text":"(Adds Wells Fargo details, executive quotes)   By David Henry and Niket  Nishant   June 28 (Reuters) - Morgan Stanley, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week.    Analysts and investors had expected the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents.    The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase & Co    said it will go to $1.00 a share from 90 cents for the third quarter.    Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25.    Wells Fargo & Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September.    The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.   CITIGROUP   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%.    A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules. (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)((Niket.Nishant@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159357544,"gmtCreate":1624943630288,"gmtModify":1703848536653,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159357544","repostId":"2147858544","repostType":2,"repost":{"id":"2147858544","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624924843,"share":"https://ttm.financial/m/news/2147858544?lang=&edition=fundamental","pubTime":"2021-06-29 08:00","market":"us","language":"en","title":"UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light","url":"https://stock-news.laohu8.com/highlight/detail?id=2147858544","media":"Reuters","summary":"(Adds Wells Fargo details, executive quotes)   By David Henry and Niket  Nishant   June 28 (Reuters)","content":"<html><body><p>(Adds Wells Fargo details, executive quotes)</p><p>   By David Henry and Niket  Nishant</p><p>   June 28 (Reuters) - <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week. </p><p>   Analysts and investors had expected </p><p>the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.</p><p>   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents. </p><p>   The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.</p><p>   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"</p><p>   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase &amp; Co    said it will go to $1.00 a share from 90 cents for the third quarter. </p><p>   Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25. </p><p>   Wells Fargo &amp; Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September. </p><p>   The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.</p><p>   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.</p><p>   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.</p><p>   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.</p><p>   CITIGROUP</p><p>   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%. </p><p>   A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.</p><p>   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.</p><p>   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.</p><p>   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.</p><p>   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules.</p><p> (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)</p><p>((Niket.Nishant@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 08:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds Wells Fargo details, executive quotes)</p><p>   By David Henry and Niket  Nishant</p><p>   June 28 (Reuters) - <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week. </p><p>   Analysts and investors had expected </p><p>the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.</p><p>   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents. </p><p>   The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.</p><p>   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"</p><p>   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase &amp; Co    said it will go to $1.00 a share from 90 cents for the third quarter. </p><p>   Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25. </p><p>   Wells Fargo &amp; Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September. </p><p>   The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.</p><p>   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.</p><p>   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.</p><p>   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.</p><p>   CITIGROUP</p><p>   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%. </p><p>   A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.</p><p>   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.</p><p>   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.</p><p>   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.</p><p>   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules.</p><p> (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)</p><p>((Niket.Nishant@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛","JPM":"摩根大通","WFC":"富国银行","MS":"摩根士丹利","C":"花旗","BAC":"美国银行"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147858544","content_text":"(Adds Wells Fargo details, executive quotes)   By David Henry and Niket  Nishant   June 28 (Reuters) - Morgan Stanley, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week.    Analysts and investors had expected the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents.    The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase & Co    said it will go to $1.00 a share from 90 cents for the third quarter.    Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25.    Wells Fargo & Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September.    The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.   CITIGROUP   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%.    A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules. (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)((Niket.Nishant@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183258147,"gmtCreate":1623333658589,"gmtModify":1704201150478,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/183258147","repostId":"1128810191","repostType":4,"repost":{"id":"1128810191","pubTimestamp":1623307595,"share":"https://ttm.financial/m/news/1128810191?lang=&edition=fundamental","pubTime":"2021-06-10 14:46","market":"us","language":"en","title":"Company spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1128810191","media":"cnbc","summary":"Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.Jefferies’ capital expenditure — or capex — indicator is “going ballistic,” the bank said in a research note Monday, and there has been a surge in corporate spending on big-ticket goods such as ships, as well as on smaller items like plant equipment.Investment bankJPMorganalso picked stocks set to get a boost from the c","content":"<div>\n<p>Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.\nJefferies’ capital ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Company spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCompany spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 14:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.\nJefferies’ capital ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1128810191","content_text":"Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.\nJefferies’ capital expenditure — or capex — indicator is “going ballistic,” the bank said in a research note Monday, and there has been a surge in corporate spending on big-ticket goods such as ships, as well as on smaller items like plant equipment.\nInvestment bankJPMorganalso picked stocks set to get a boost from the capital expenditure “bright spot.” It created two new lists of stocks likely to benefit from President Joe Biden’s $2.3 trillion infrastructure plan, as well as the E.U.’s 750 billion euro ($912 billion) recovery fund.\nThe banks’ stock picks include:\nIndustrials stocks\nMost of Jefferies buy-rated picks are industrials. It said U.S. firms were benefiting from a “huge turnaround” in capex and its picks include semiconductor firmAnalog Devicesand truck-makerPaccar. It also likes farm equipment companyJohn Deere, as well as air conditioning company Carrier Global.\nWhen it comes to international corporate spending, the analysts, led by Sean Darby, said: “We were wrong! It is not just the US that is enjoying a huge turnaround in capital investment intentions – even outside of Tech – but also the Rest-of-the-World.”\nJefferies’ international picks include Swedish leisure product manufacturerDometic Groupand German luxury RV-makerKnaus Tabbert, as well as Japanese firmHitachi Constructionand Chinese engineering firmChina Railway Group. All are buy-rated.\nEnergy and materials\nIn a note Monday, JPMorgan said it had put together two baskets of stocks: those set to benefit from President Biden’s infrastructure plan, and those likely to do well from the EU recovery fund. Firms that appear on both lists include steel firmArcelorMittaland Spanish energy companiesEDP RenewablesandIberdrola.\nTechnology and communications\nAnalysts from JPMorgan also picked semiconductor firmsInfineon TechnologiesandSTMicroelectronicsfor both their U.S. and European lists, as well as German firmDeutsche Telekom.\nFirms that appear on both Jefferies’ and JPMorgan’s lists include medical technology groupSiemens Healthineers, French train manufacturerAlstomand security firmAssa Abloy.\nA number of factors have combined to stimulate a capital spending surge, according to Jefferies’ analysts. These include old equipment that needs replacing, “buoyant” CEO confidence, an earnings turnaround leaving balance sheets “flush with cash,” and low industrial inventories.\n“Our US capex indicator has quite literally gone ballistic. It took around six years from the GFC [global financial crisis] to 2015 before a capex recovery emerged in the previous cycle. This one has taken approximately 13 months and has surged to the highest reading in history,” Jefferies’ analysts wrote.\nFor JPMorgan, company profits have also meant a surge in spending. “Corporate capex is on an accelerating path this year, given the strong rebound in corporate profitability, where profits have tended to lead capex pretty consistently. Further, bank lending standards are continuing to improve, which helps capex decisions,” the bank’s analysts wrote.","news_type":1},"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183259961,"gmtCreate":1623333572453,"gmtModify":1704201146262,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183259961","repostId":"1185996577","repostType":4,"repost":{"id":"1185996577","pubTimestamp":1623328186,"share":"https://ttm.financial/m/news/1185996577?lang=&edition=fundamental","pubTime":"2021-06-10 20:29","market":"us","language":"en","title":"Baird says GameStop's turnaround plan remains a mystery, predicts 90% stock decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1185996577","media":"cnbc","summary":"The plan to turn beleaguered retailerGameStopinto an e-commerce powerhouse is still murky five month","content":"<div>\n<p>The plan to turn beleaguered retailerGameStopinto an e-commerce powerhouse is still murky five months after the stock first caught fire, according to investment firm Baird.\nOn Wednesday, the company ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/baird-says-gamestops-turnaround-plan-remains-a-mystery-predicts-90percent-stock-decline.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baird says GameStop's turnaround plan remains a mystery, predicts 90% stock decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaird says GameStop's turnaround plan remains a mystery, predicts 90% stock decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 20:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/10/baird-says-gamestops-turnaround-plan-remains-a-mystery-predicts-90percent-stock-decline.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The plan to turn beleaguered retailerGameStopinto an e-commerce powerhouse is still murky five months after the stock first caught fire, according to investment firm Baird.\nOn Wednesday, the company ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/baird-says-gamestops-turnaround-plan-remains-a-mystery-predicts-90percent-stock-decline.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://www.cnbc.com/2021/06/10/baird-says-gamestops-turnaround-plan-remains-a-mystery-predicts-90percent-stock-decline.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1185996577","content_text":"The plan to turn beleaguered retailerGameStopinto an e-commerce powerhouse is still murky five months after the stock first caught fire, according to investment firm Baird.\nOn Wednesday, the company reported stronger-than-expected revenues for thefirst quarter, helped by console sales, and announced that it had tapped twoAmazon veterans for roles as CEO and CFO. They join board member and Chewy co-founder Ryan Cohen as high-level leaders at the company with e-commerce experience.\nHowever, the company declined to provide forward guidance and announced that it might sell up to 5 million shares. The stock was down in premarket trading Thursday.\nBaird analyst Colin Sebastian reiterated his neutral rating on the stock after the earnings report, saying that the eventual turnaround for the company plan remained unclear.\n“As GameStop’s board continues to shuffle the management deck, the goal to transform into a ‘technology’ company that delights gamers remains mostly a mystery, particularly as the video game industry accelerates the shift toward downloads, streaming and cloud services,” the note said. “No doubt the console transition period is providing a lifeline, but games are not dog food, and investors deserve more than memes to value a company’s fundamental, long-term prospects.”\nBaird has a price target of $25 per share for GameStop, more than 90% below where the stock closed on Wednesday.\nThe firm raised its estimates for the second quarter, but said that the recent boost from console sales wouldn’t last forever.\n“We are increasing our Q2 revenue and EPS estimates to reflect the favorable impact of easing console supply constraints; however, we are also slightly lowering our Q3 and Q4 estimates as some hardware demand will likely be pulled forward as availability improves faster than previously expected,” the note said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183250991,"gmtCreate":1623333540913,"gmtModify":1704201145128,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183250991","repostId":"1153379858","repostType":4,"isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180946612,"gmtCreate":1623172741636,"gmtModify":1704197712201,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Good buy","listText":"Good buy","text":"Good buy","images":[{"img":"https://static.tigerbbs.com/a6d400477c6dd932602dbc8dbbe1525a","width":"720","height":"1316"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180946612","isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":107031741,"gmtCreate":1620432481083,"gmtModify":1704343543660,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/107031741","repostId":"1106240370","repostType":4,"repost":{"id":"1106240370","pubTimestamp":1620432184,"share":"https://ttm.financial/m/news/1106240370?lang=&edition=fundamental","pubTime":"2021-05-08 08:03","market":"us","language":"en","title":"Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues","url":"https://stock-news.laohu8.com/highlight/detail?id=1106240370","media":"CNBC","summary":"KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines ","content":"<div>\n<p>KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 08:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1106240370","content_text":"KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing of Covid shots.The Biden administration endorsed the waiver proposal days earlier, in service of expanding vaccine distribution to lower-income nations currently being battered by the pandemic.But Bourla, whose company produces one of three vaccines approved for emergency use in the U.S., said he believes \"categorically\" that the waiver proposal will \"create more problems.\"PfizerCEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines —a proposal President Joe Biden just endorsed— would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing of Covid shots.The Biden administration said Wednesday it supports the limited waiver of intellectual property rules in service of expanding vaccine distribution to the lower-income nations currently being battered bythe pandemic.But Bourla, whose company produces one of three vaccines approved for emergency use in the U.S., said that he believes “categorically” that the waiver proposal will “create more problems.”“Currently, infrastructure is not the bottleneck for us manufacturing faster,” Bourla wrote in a dear colleagueletter posted on LinkedIn. “The restriction is the scarcity of highly specialized raw materials needed to produce our vaccine.”Pfizer’s vaccine requires 280 different materials and components that are sourced from 19 countries around the world, Bourla said. He contended that without patent protections, entities with much less experienced than Pfizer at manufacturing vaccines will start competing for the same ingredients.“Right now, virtually every single gram of raw material produced is shipped immediately into our manufacturing facilities and is converted immediately and reliably to vaccines that are shipped immediately around the world,” Bourla wrote.He predicted that the proposed waiver “threatens to disrupt the flow of raw materials.”“It will unleash a scramble for the critical inputs we require in order to make a safe and effective vaccine,” Bourla wrote.“Entities with little or no experience in manufacturing vaccines are likely to chase the very raw materials we require to scale our production, putting the safety and security of all at risk,” the CEO wrote.The White House referred CNBC’s outreach on Bourla’s post to the Office of U.S. Trade Representative, which did not immediately respond to a request for comment.World Trade Organization leaders have recently urged member nations to come to an agreement on the potential vaccine patent waivers. But even with the U.S. backing, a deal is hardly guaranteed, since the WTO’s rulings are based on consensus, requiring approval from all 164 members.Germany, a WTO member and the largest economy in Europe, came out against the waiver proposal on Thursday.BioNTech, which partnered with Pfizer in developing the vaccine, is based in Germany.Bourla on LinkedIn also expressed concern that the possible vaccine waivers “will disincentivize anyone else from taking a big risk.”“The recent rhetoric will not discourage us from continuing investing in science. But I am not sure if the same is true for the thousands of small biotech innovators that are totally dependent on accessing capital from investors who invest only on the premise that their intellectual property will be protected,” the CEO wrote.PhRMA, the pharmaceutical industry interest groups whosemember companies includePfizer andJohnson & Johnson, another U.S. vaccine provider, called the waiver proposal “an unprecedented step that will undermine our global response to the pandemic and compromise safety.”Meanwhile, CEO Stephane Bancel ofModerna, maker of the other U.S.-approved Covid shot, saidhe wasn’t concerned about the possible waivers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":107098481,"gmtCreate":1620431952643,"gmtModify":1704343529903,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/107098481","repostId":"1199435328","repostType":4,"repost":{"id":"1199435328","pubTimestamp":1620430312,"share":"https://ttm.financial/m/news/1199435328?lang=&edition=fundamental","pubTime":"2021-05-08 07:31","market":"hk","language":"en","title":"WHO approves Covid vaccine made by China's Sinopharm for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=1199435328","media":"CNBC","summary":"KEY POINTSThe World Health Organization said it has approved for emergency use a coronavirus vaccine","content":"<div>\n<p>KEY POINTSThe World Health Organization said it has approved for emergency use a coronavirus vaccine developed by the Chinese state-owned pharmaceutical group Sinopharm.Beijing's Covid vaccine is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/who-approves-covid-vaccine-made-by-chinas-sinopharm-for-emergency-use.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WHO approves Covid vaccine made by China's Sinopharm for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWHO approves Covid vaccine made by China's Sinopharm for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/05/07/who-approves-covid-vaccine-made-by-chinas-sinopharm-for-emergency-use.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe World Health Organization said it has approved for emergency use a coronavirus vaccine developed by the Chinese state-owned pharmaceutical group Sinopharm.Beijing's Covid vaccine is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/who-approves-covid-vaccine-made-by-chinas-sinopharm-for-emergency-use.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","PFE":"辉瑞","MRNA":"Moderna, Inc.","01099":"国药控股"},"source_url":"https://www.cnbc.com/2021/05/07/who-approves-covid-vaccine-made-by-chinas-sinopharm-for-emergency-use.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1199435328","content_text":"KEY POINTSThe World Health Organization said it has approved for emergency use a coronavirus vaccine developed by the Chinese state-owned pharmaceutical group Sinopharm.Beijing's Covid vaccine is recommended for adults 18 years and up with a two-dose regimen, WHO Director-General Tedros Adhanom Ghebreyesus said at a press briefing.The new addition to the list of usable vaccine options could hasten efforts to control the spread of Covid-19 and its variant forms, which are driving new infections in many parts of the world.The World Health Organization said Friday it has approved for emergency use a coronavirus vaccine developed by Chinese state-owned pharmaceutical group Sinopharm.Beijing's Covid vaccine is recommended for adults 18 years and up with a two-dose regimen, WHO Director-General Tedros Adhanom Ghebreyesus said at a press briefing.The new addition to the list of usable vaccine options could hasten efforts to control the spread ofCovid-19and its variant forms, which are driving new infections in many parts of the world.“Solving the vaccine crisis requires that we pull out all the stops,” Tedros said.Sinopharm’s shot is the sixth to receive the WHO’s approval for “safety, efficacy and quality,” he said.“Vaccines remain a vital tool. But right now, the volume and distribution of vaccines is insufficient to end the pandemic, without the sustained and tailored application of public health measures that we know work,” Tedros said.“The pandemic has shown that when health is at risk, everything is at risk. But when health is protected and promoted, individuals, families, communities, economies and nations can thrive,” he said.The state-owned drugmaker’s two-dose Covid shot has already been approved for emergency use in China, the United Arab Emirates and Bahrain.Another Chinese shot, made by the private company Sinovac, has not yet been approved by the WHO.In the U.S., vaccines developed byPfizer-BioNTech,ModernaandJohnson & Johnsonhave received emergency use authorizations by theFood and Drug Administration.The WHO has granted emergency validation for those three shots, as well as for vaccines produced byAstrazeneca-SK BIO and the Serum Institute of India.","news_type":1},"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":159343286,"gmtCreate":1624943742645,"gmtModify":1703848541337,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice update","listText":"Nice update","text":"Nice update","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159343286","repostId":"2147837316","repostType":2,"repost":{"id":"2147837316","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624921533,"share":"https://ttm.financial/m/news/2147837316?lang=&edition=fundamental","pubTime":"2021-06-29 07:05","market":"us","language":"en","title":"Tech stock rally sends S&P and Nasdaq to record highs","url":"https://stock-news.laohu8.com/highlight/detail?id=2147837316","media":"Reuters","summary":" - The Nasdaq and S&P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&P 500 and the Nasdaq.The S&P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.In contrast, cycl","content":"<p>(Reuters) - The Nasdaq and S&amp;P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.</p>\n<p>Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&amp;P 500 and the Nasdaq.</p>\n<p>The S&amp;P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.</p>\n<p>In contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&amp;P 500, down by 0.81% and 3.33%, respectively.</p>\n<p>“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.</p>\n<p>Stovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&amp;P 500 companies is expected to top 60%.</p>\n<p>The Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&amp;P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.</p>\n<p>Both the S&amp;P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.</p>\n<p>“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.</p>\n<p>Facebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.</p>\n<p>On the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.</p>\n<p>With the S&amp;P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.</p>\n<p>On the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.</p>\n<p>Volume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech stock rally sends S&P and Nasdaq to record highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech stock rally sends S&P and Nasdaq to record highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 07:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Reuters) - The Nasdaq and S&amp;P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.</p>\n<p>Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&amp;P 500 and the Nasdaq.</p>\n<p>The S&amp;P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.</p>\n<p>In contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&amp;P 500, down by 0.81% and 3.33%, respectively.</p>\n<p>“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.</p>\n<p>Stovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&amp;P 500 companies is expected to top 60%.</p>\n<p>The Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&amp;P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.</p>\n<p>Both the S&amp;P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.</p>\n<p>“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.</p>\n<p>Facebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.</p>\n<p>On the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.</p>\n<p>With the S&amp;P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.</p>\n<p>On the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.</p>\n<p>Volume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WBA":"沃尔格林联合博姿","PSQ":"纳指反向ETF","NDAQ":"纳斯达克OMX交易所",".SPX":"S&P 500 Index","TQQQ":"纳指三倍做多ETF","QID":"纳指两倍做空ETF","NVDA":"英伟达","MU":"美光科技",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","NFLX":"奈飞",".DJI":"道琼斯","SQQQ":"纳指三倍做空ETF","TWTR":"Twitter"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147837316","content_text":"(Reuters) - The Nasdaq and S&P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.\nBig tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&P 500 and the Nasdaq.\nThe S&P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.\nIn contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&P 500, down by 0.81% and 3.33%, respectively.\n“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.\nStovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&P 500 companies is expected to top 60%.\nThe Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.\nBoth the S&P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.\n“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.\nFacebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.\nOn the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.\nWith the S&P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.\nOn the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.\nThe S&P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.\nVolume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183250991,"gmtCreate":1623333540913,"gmtModify":1704201145128,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183250991","repostId":"1153379858","repostType":4,"isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159349785,"gmtCreate":1624943707847,"gmtModify":1703848540206,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159349785","repostId":"2147837316","repostType":2,"repost":{"id":"2147837316","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624921533,"share":"https://ttm.financial/m/news/2147837316?lang=&edition=fundamental","pubTime":"2021-06-29 07:05","market":"us","language":"en","title":"Tech stock rally sends S&P and Nasdaq to record highs","url":"https://stock-news.laohu8.com/highlight/detail?id=2147837316","media":"Reuters","summary":" - The Nasdaq and S&P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&P 500 and the Nasdaq.The S&P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.In contrast, cycl","content":"<p>(Reuters) - The Nasdaq and S&amp;P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.</p>\n<p>Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&amp;P 500 and the Nasdaq.</p>\n<p>The S&amp;P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.</p>\n<p>In contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&amp;P 500, down by 0.81% and 3.33%, respectively.</p>\n<p>“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.</p>\n<p>Stovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&amp;P 500 companies is expected to top 60%.</p>\n<p>The Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&amp;P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.</p>\n<p>Both the S&amp;P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.</p>\n<p>“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.</p>\n<p>Facebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.</p>\n<p>On the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.</p>\n<p>With the S&amp;P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.</p>\n<p>On the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.</p>\n<p>Volume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech stock rally sends S&P and Nasdaq to record highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech stock rally sends S&P and Nasdaq to record highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 07:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Reuters) - The Nasdaq and S&amp;P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.</p>\n<p>Big tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&amp;P 500 and the Nasdaq.</p>\n<p>The S&amp;P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.</p>\n<p>In contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&amp;P 500, down by 0.81% and 3.33%, respectively.</p>\n<p>“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.</p>\n<p>Stovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&amp;P 500 companies is expected to top 60%.</p>\n<p>The Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&amp;P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.</p>\n<p>Both the S&amp;P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.</p>\n<p>“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.</p>\n<p>Facebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.</p>\n<p>On the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.</p>\n<p>With the S&amp;P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.</p>\n<p>On the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.</p>\n<p>Volume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WBA":"沃尔格林联合博姿","PSQ":"纳指反向ETF","NDAQ":"纳斯达克OMX交易所",".SPX":"S&P 500 Index","TQQQ":"纳指三倍做多ETF","QID":"纳指两倍做空ETF","NVDA":"英伟达","MU":"美光科技",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","NFLX":"奈飞",".DJI":"道琼斯","SQQQ":"纳指三倍做空ETF","TWTR":"Twitter"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147837316","content_text":"(Reuters) - The Nasdaq and S&P 500 hit all-time highs on Monday, fueled by tech stocks as investors expect a robust earnings season while interest rates remain low.\nBig tech companies including Facebook Inc, Netflix Inc, Twitter Inc and Nvidia Corp were among the biggest boosts to the S&P 500 and the Nasdaq.\nThe S&P 500 continued its recent momentum after paring some earlier losses, recording its third record high in a row, after logging its best weekly performance in 20 weeks last Friday.\nIn contrast, cyclical sectors dropped sharply amid fears over a spike in COVID-19 cases across Asia. Financials and energy posted the biggest sectoral loss on S&P 500, down by 0.81% and 3.33%, respectively.\n“It’s end of the quarter and investors may want to take some profits and rotate out of energy and stick with tech,” said Sam Stovall, chief investment strategist at CFRA Research in New York.\nStovall expects stocks should continue their near-term climb as investors await the new earnings season, in which year-over-year earnings growth of S&P 500 companies is expected to top 60%.\nThe Dow Jones Industrial Average fell 150.57 points, or 0.44%, to close at 34,283.27. The S&P 500 pared earlier losses and advanced from Friday’s record high by gaining 9.91 points, or 0.23%, to 4,290.61. The Nasdaq Composite added 140.12 points, or 0.98%, to 14,500.51.\nBoth the S&P 500 and the Nasdaq hit a series of record highs last week. the tech-heavy Nasdaq’s 5% gain in June is outpacing its peers as investors pile back in to tech-oriented growth stocks on diminishing worries about runaway inflation.\n“We believe with the Fed putting a realistic goal post, investors now have much more of a risk-on mentality going into the second half of the year. A lot of these tech names have underperformed, while fundamentals were very robust going into the June quarter,” said Wedbush Securities analyst Daniel Ives, who expects the Nasdaq to hit 16,000 by year-end.\nFacebook jumped over 4% as a U.S. judge granted the company’s motion to dismiss a Federal Trade Commission lawsuit. The social media giant finished Monday with over $1 trillion in market capitalization.\nOn the Nasdaq 100, the largest gainer was Nvidia Corp, which rose 5.0% after major chip makers Broadcom Inc, Marvell and Taiwan-based MediaTek endorsed its $40 billion deal to buy UK chip designer Arm.\nWith the S&P 500 up almost 14% as the first half of 2021 draws to a close, activity in some areas of the market indicates concern over potential volatility, with some investors suggesting the market may be overdue for a significant pullback.\nOn the economic front, investor attention will be focused on consumer confidence data, a private jobs report and a crucial monthly employment report due later this week. Quarterly results from Micron Technology Inc and Walgreens Boots Alliance are also slated for this week.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.09-to-1 ratio favored decliners.\nThe S&P 500 posted 36 new 52-week highs and no new lows; the Nasdaq Composite recorded 100 new highs and 31 new lows.\nVolume on U.S. exchanges was 9.55 billion shares, compared with the 11.17 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183258147,"gmtCreate":1623333658589,"gmtModify":1704201150478,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/183258147","repostId":"1128810191","repostType":4,"repost":{"id":"1128810191","pubTimestamp":1623307595,"share":"https://ttm.financial/m/news/1128810191?lang=&edition=fundamental","pubTime":"2021-06-10 14:46","market":"us","language":"en","title":"Company spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1128810191","media":"cnbc","summary":"Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.Jefferies’ capital expenditure — or capex — indicator is “going ballistic,” the bank said in a research note Monday, and there has been a surge in corporate spending on big-ticket goods such as ships, as well as on smaller items like plant equipment.Investment bankJPMorganalso picked stocks set to get a boost from the c","content":"<div>\n<p>Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.\nJefferies’ capital ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Company spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCompany spending is 'going ballistic.' Wall Street analysts expect these stocks to benefit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 14:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.\nJefferies’ capital ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.cnbc.com/2021/06/10/investment-banks-pick-top-industrials-and-tech-stocks-to-buy.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1128810191","content_text":"Firms are “flush with cash” and spending is at its highest in history, according to investment firmJefferies, which recommended dozens of U.S. and global stocks to play the trend.\nJefferies’ capital expenditure — or capex — indicator is “going ballistic,” the bank said in a research note Monday, and there has been a surge in corporate spending on big-ticket goods such as ships, as well as on smaller items like plant equipment.\nInvestment bankJPMorganalso picked stocks set to get a boost from the capital expenditure “bright spot.” It created two new lists of stocks likely to benefit from President Joe Biden’s $2.3 trillion infrastructure plan, as well as the E.U.’s 750 billion euro ($912 billion) recovery fund.\nThe banks’ stock picks include:\nIndustrials stocks\nMost of Jefferies buy-rated picks are industrials. It said U.S. firms were benefiting from a “huge turnaround” in capex and its picks include semiconductor firmAnalog Devicesand truck-makerPaccar. It also likes farm equipment companyJohn Deere, as well as air conditioning company Carrier Global.\nWhen it comes to international corporate spending, the analysts, led by Sean Darby, said: “We were wrong! It is not just the US that is enjoying a huge turnaround in capital investment intentions – even outside of Tech – but also the Rest-of-the-World.”\nJefferies’ international picks include Swedish leisure product manufacturerDometic Groupand German luxury RV-makerKnaus Tabbert, as well as Japanese firmHitachi Constructionand Chinese engineering firmChina Railway Group. All are buy-rated.\nEnergy and materials\nIn a note Monday, JPMorgan said it had put together two baskets of stocks: those set to benefit from President Biden’s infrastructure plan, and those likely to do well from the EU recovery fund. Firms that appear on both lists include steel firmArcelorMittaland Spanish energy companiesEDP RenewablesandIberdrola.\nTechnology and communications\nAnalysts from JPMorgan also picked semiconductor firmsInfineon TechnologiesandSTMicroelectronicsfor both their U.S. and European lists, as well as German firmDeutsche Telekom.\nFirms that appear on both Jefferies’ and JPMorgan’s lists include medical technology groupSiemens Healthineers, French train manufacturerAlstomand security firmAssa Abloy.\nA number of factors have combined to stimulate a capital spending surge, according to Jefferies’ analysts. These include old equipment that needs replacing, “buoyant” CEO confidence, an earnings turnaround leaving balance sheets “flush with cash,” and low industrial inventories.\n“Our US capex indicator has quite literally gone ballistic. It took around six years from the GFC [global financial crisis] to 2015 before a capex recovery emerged in the previous cycle. This one has taken approximately 13 months and has surged to the highest reading in history,” Jefferies’ analysts wrote.\nFor JPMorgan, company profits have also meant a surge in spending. “Corporate capex is on an accelerating path this year, given the strong rebound in corporate profitability, where profits have tended to lead capex pretty consistently. Further, bank lending standards are continuing to improve, which helps capex decisions,” the bank’s analysts wrote.","news_type":1},"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":107031741,"gmtCreate":1620432481083,"gmtModify":1704343543660,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/107031741","repostId":"1106240370","repostType":4,"repost":{"id":"1106240370","pubTimestamp":1620432184,"share":"https://ttm.financial/m/news/1106240370?lang=&edition=fundamental","pubTime":"2021-05-08 08:03","market":"us","language":"en","title":"Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues","url":"https://stock-news.laohu8.com/highlight/detail?id=1106240370","media":"CNBC","summary":"KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines ","content":"<div>\n<p>KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 08:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1106240370","content_text":"KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing of Covid shots.The Biden administration endorsed the waiver proposal days earlier, in service of expanding vaccine distribution to lower-income nations currently being battered by the pandemic.But Bourla, whose company produces one of three vaccines approved for emergency use in the U.S., said he believes \"categorically\" that the waiver proposal will \"create more problems.\"PfizerCEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines —a proposal President Joe Biden just endorsed— would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing of Covid shots.The Biden administration said Wednesday it supports the limited waiver of intellectual property rules in service of expanding vaccine distribution to the lower-income nations currently being battered bythe pandemic.But Bourla, whose company produces one of three vaccines approved for emergency use in the U.S., said that he believes “categorically” that the waiver proposal will “create more problems.”“Currently, infrastructure is not the bottleneck for us manufacturing faster,” Bourla wrote in a dear colleagueletter posted on LinkedIn. “The restriction is the scarcity of highly specialized raw materials needed to produce our vaccine.”Pfizer’s vaccine requires 280 different materials and components that are sourced from 19 countries around the world, Bourla said. He contended that without patent protections, entities with much less experienced than Pfizer at manufacturing vaccines will start competing for the same ingredients.“Right now, virtually every single gram of raw material produced is shipped immediately into our manufacturing facilities and is converted immediately and reliably to vaccines that are shipped immediately around the world,” Bourla wrote.He predicted that the proposed waiver “threatens to disrupt the flow of raw materials.”“It will unleash a scramble for the critical inputs we require in order to make a safe and effective vaccine,” Bourla wrote.“Entities with little or no experience in manufacturing vaccines are likely to chase the very raw materials we require to scale our production, putting the safety and security of all at risk,” the CEO wrote.The White House referred CNBC’s outreach on Bourla’s post to the Office of U.S. Trade Representative, which did not immediately respond to a request for comment.World Trade Organization leaders have recently urged member nations to come to an agreement on the potential vaccine patent waivers. But even with the U.S. backing, a deal is hardly guaranteed, since the WTO’s rulings are based on consensus, requiring approval from all 164 members.Germany, a WTO member and the largest economy in Europe, came out against the waiver proposal on Thursday.BioNTech, which partnered with Pfizer in developing the vaccine, is based in Germany.Bourla on LinkedIn also expressed concern that the possible vaccine waivers “will disincentivize anyone else from taking a big risk.”“The recent rhetoric will not discourage us from continuing investing in science. But I am not sure if the same is true for the thousands of small biotech innovators that are totally dependent on accessing capital from investors who invest only on the premise that their intellectual property will be protected,” the CEO wrote.PhRMA, the pharmaceutical industry interest groups whosemember companies includePfizer andJohnson & Johnson, another U.S. vaccine provider, called the waiver proposal “an unprecedented step that will undermine our global response to the pandemic and compromise safety.”Meanwhile, CEO Stephane Bancel ofModerna, maker of the other U.S.-approved Covid shot, saidhe wasn’t concerned about the possible waivers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":107098481,"gmtCreate":1620431952643,"gmtModify":1704343529903,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/107098481","repostId":"1199435328","repostType":4,"repost":{"id":"1199435328","pubTimestamp":1620430312,"share":"https://ttm.financial/m/news/1199435328?lang=&edition=fundamental","pubTime":"2021-05-08 07:31","market":"hk","language":"en","title":"WHO approves Covid vaccine made by China's Sinopharm for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=1199435328","media":"CNBC","summary":"KEY POINTSThe World Health Organization said it has approved for emergency use a coronavirus vaccine","content":"<div>\n<p>KEY POINTSThe World Health Organization said it has approved for emergency use a coronavirus vaccine developed by the Chinese state-owned pharmaceutical group Sinopharm.Beijing's Covid vaccine is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/who-approves-covid-vaccine-made-by-chinas-sinopharm-for-emergency-use.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WHO approves Covid vaccine made by China's Sinopharm for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWHO approves Covid vaccine made by China's Sinopharm for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/05/07/who-approves-covid-vaccine-made-by-chinas-sinopharm-for-emergency-use.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSThe World Health Organization said it has approved for emergency use a coronavirus vaccine developed by the Chinese state-owned pharmaceutical group Sinopharm.Beijing's Covid vaccine is ...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/who-approves-covid-vaccine-made-by-chinas-sinopharm-for-emergency-use.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","PFE":"辉瑞","MRNA":"Moderna, Inc.","01099":"国药控股"},"source_url":"https://www.cnbc.com/2021/05/07/who-approves-covid-vaccine-made-by-chinas-sinopharm-for-emergency-use.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1199435328","content_text":"KEY POINTSThe World Health Organization said it has approved for emergency use a coronavirus vaccine developed by the Chinese state-owned pharmaceutical group Sinopharm.Beijing's Covid vaccine is recommended for adults 18 years and up with a two-dose regimen, WHO Director-General Tedros Adhanom Ghebreyesus said at a press briefing.The new addition to the list of usable vaccine options could hasten efforts to control the spread of Covid-19 and its variant forms, which are driving new infections in many parts of the world.The World Health Organization said Friday it has approved for emergency use a coronavirus vaccine developed by Chinese state-owned pharmaceutical group Sinopharm.Beijing's Covid vaccine is recommended for adults 18 years and up with a two-dose regimen, WHO Director-General Tedros Adhanom Ghebreyesus said at a press briefing.The new addition to the list of usable vaccine options could hasten efforts to control the spread ofCovid-19and its variant forms, which are driving new infections in many parts of the world.“Solving the vaccine crisis requires that we pull out all the stops,” Tedros said.Sinopharm’s shot is the sixth to receive the WHO’s approval for “safety, efficacy and quality,” he said.“Vaccines remain a vital tool. But right now, the volume and distribution of vaccines is insufficient to end the pandemic, without the sustained and tailored application of public health measures that we know work,” Tedros said.“The pandemic has shown that when health is at risk, everything is at risk. But when health is protected and promoted, individuals, families, communities, economies and nations can thrive,” he said.The state-owned drugmaker’s two-dose Covid shot has already been approved for emergency use in China, the United Arab Emirates and Bahrain.Another Chinese shot, made by the private company Sinovac, has not yet been approved by the WHO.In the U.S., vaccines developed byPfizer-BioNTech,ModernaandJohnson & Johnsonhave received emergency use authorizations by theFood and Drug Administration.The WHO has granted emergency validation for those three shots, as well as for vaccines produced byAstrazeneca-SK BIO and the Serum Institute of India.","news_type":1},"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159342994,"gmtCreate":1624943960018,"gmtModify":1703848548141,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Hello","listText":"Hello","text":"Hello","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159342994","repostId":"2147449837","repostType":2,"repost":{"id":"2147449837","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1624916160,"share":"https://ttm.financial/m/news/2147449837?lang=&edition=fundamental","pubTime":"2021-06-29 05:36","market":"hk","language":"en","title":"Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away","url":"https://stock-news.laohu8.com/highlight/detail?id=2147449837","media":"Dow Jones","summary":"MW Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccinatio","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away\n</p>\n<p>\n  Jaimy LeeJillian BermanAndrew Keshner \n</p>\n<p>\n  Upgrade from emergency-use authorizations could open the door to vaccine mandates from more employers -- including the U.S. military -- and schools \n</p>\n<p>\n  The \"full\" approval of Pfizer's and Moderna's COVID-19 vaccines will almost certainly boost sagging vaccination rates in the U.S., though the Food and Drug Administration's decision might not come until the end of the year. \n</p>\n<p>\n  The Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and Moderna Inc. <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> vaccines, along with Johnson &amp; Johnson's <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> COVID-19 shot, have received emergency-use authorization, a less rigorous category of approval granted by the FDA that allowed the vaccines to be distributed more quickly during a critical stage of the public health emergency. \n</p>\n<p>\n  Though an FDA decision isn't required until the end of the year, people are already evaluating how a formal approval would impact lagging vaccination rates in the U.S. amid a murky landscape for required immunization in the U.S. \n</p>\n<p>\n  More than 153 million people in the U.S., or roughly 46% of the total population, have voluntarily chosen to get vaccinated, according to data  from the Centers for Disease Control and Prevention. \n</p>\n<p>\n  But a recent slowdown  \n</p>\n<p>\n  All signs point to a boost, whatever its magnitude, in the ongoing COVID-19 vaccination campaign in the U.S. if and when the vaccines are formally approved. \n</p>\n<p>\n  Approval will allow drug manufacturers to advertise their vaccines and, in some cases, set their own prices. It may also mean that employers and schools will have an established legal precedent to require vaccination, and it could tip people in the wait-and-see category to get vaccinated once they know the vaccines have gone through a more rigorous regulatory screening. \n</p>\n<p>\n  \"A third of people who are unvaccinated said that they'd be more likely to get the vaccine if ... <a href=\"https://laohu8.com/S/AONE\">one</a> of the vaccines received full approval from the FDA,\" said Liz Hamel, director of public opinion and survey research at the Henry J. Kaiser Family Foundation, which has studied COVID-19 vaccine hesitancy. \n</p>\n<p>\n  A full FDA approval could help the lagging vaccination rate in the U.S. \n</p>\n<p>\n  About 12% of unvaccinated people in the U.S. are part of the wait-and-see group, according to the Kaiser Family Foundation. They tend to be young adults and Black adults. \n</p>\n<p>\n  For some people, approval sounds safer than emergency authorization. \"We hear people say, it's just experimental at this point. It's not approved yet,\" Hamel said. \"They hear terms like 'emergency,' and then they are just still cautious.\" \n</p>\n<p>\n  Arkansas Gov. Asa Hutchinson said the state needs full approval to combat vaccine hesitancy. \"It was approved as emergency use,\" the Republican told \"Face the Nation\"  this weekend. \"And so, for that reason, you can't mandate it.\" \n</p>\n<p>\n  An FDA approval for a COVID-19 vaccine requires six months of follow-up data from the clinical trial, three times the two months' worth of follow-up data  used to inform emergency authorization. \n</p>\n<p>\n  The regulator has 60 days after the companies submit their applications to decide if it is going to grant \"priority review,\" a designation that requires the federal agency to make a decision whether or not to approve the vaccine within six months. Pfizer said it submitted its application on May 7; Moderna followed, on June 1, with its submission. \n</p>\n<p>\n  Between 6% and 7% of unvaccinated Americans say they'll get a shot only if they are required by an employer or a school, or to travel. While some employers already require vaccinations -- the Houston Methodist hospital system in Texas went to legal lengths  for returning employees -- these kinds of requirements are not the norm. \n</p>\n<p>\n  The U.S. military, with its 1.3 million active-duty members, has not required vaccination but has suggested  he would leave that decision in the hands of the military brass. \n</p>\n<p>\n  \"Some people will respond to incentives, and some will respond to requirements,\" the Kaiser Family Foundation's Hamel said. \n</p>\n<p>\n  We'll see TV ads promoting vaccines. \n</p>\n<p>\n  Right now, drug companies are limited in what they are allowed to say about their vaccines based on the rules of emergency authorization. They can't advertise the vaccines to the public or to prescribers -- or proactively explain the safety and effectiveness of their shots. \n</p>\n<p>\n  \"You essentially have to stick to the script that's in the EUA,\" said Cody Powers, a COVID-19 vaccine expert at ZS, a pharmaceutical consulting firm. \"You can't make explicit claims about safety and effectiveness.\" \n</p>\n<p>\n  If and when FDA approvals are granted, companies like Moderna and Pfizer may stay cautious in their approach to marketing COVID-19 vaccines in the U.S. Traditionally, pharmaceutical companies hold off on putting out direct-to-consumer ads for six months after approval as a result of concerns about aggressive marketing practices. In this case, there likely will be worries about corporate profit motivations during a global pandemic. \n</p>\n<p>\n  \"If they feel like they're jeopardizing both their own perception and the success of overall inoculations in the U.S., they might step back,\" Powers said. \n</p>\n<p>\n  Drug manufacturers usually start with disease-awareness campaigns for new products and then later launch brand campaigns that seek to either raise awareness of their particular offering or to differentiate it. \n</p>\n<p>\n  But this moment in time is very different. The American public already knows about the vaccines and their makers. In fact, many people are well-versed in efficacy rates from the clinical trials and even how the FDA regulatory process works. That means we already have perceptions of each vaccine, whether that's sillier ones, like the TikTok idea that Pfizer's vaccine is for \"hot\" people . \n</p>\n<p>\n  \"When you can make claims about the vaccine, then all the promotional machinery around that claim turns on,\" Powers said. \"It's a really weird situation for most manufacturers, where they're actually having to make decisions about whether to just roll with what they've inherited or try to change people's perceptions.\" \n</p>\n<p>\n  The price of at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> vaccine may eventually go up. \n</p>\n<p>\n  Moderna will also gain more control over the pricing of its vaccine once it is approved, according to remarks made earlier this month by CEO Stéphane Bancel. \n</p>\n<p>\n  The price of Moderna's shot works out to $15 per dose, in comparison with the $19.50 charged by Pfizer , had more price-setting freedom. \n</p>\n<p>\n  With approval, \"we should be able to go into the private market,\" Moderna's Bancel told investors. \"The price is pretty low because at the time the deal was done there was no clinical data.\" -- Jaimy Lee \n</p>\n<p>\n  Colleges are going to lead the way when it comes to requiring vaccines in educational settings. \n</p>\n<p>\n  Hundreds of colleges  in the U.S. have announced vaccine requirements for students and, less often, employees. But full FDA approval is expected to broaden both the number of schools mandating vaccination and the scope of the requirements in place. \n</p>\n<p>\n  The California Institute of Technology said  everyone in its community to get vaccinated. \n</p>\n<p>\n  (MORE TO FOLLOW) Dow Jones Newswires\n</p>\n<p>\n  June 28, 2021 17:36 ET (21:36 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFull FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-29 05:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away\n</p>\n<p>\n  Jaimy LeeJillian BermanAndrew Keshner \n</p>\n<p>\n  Upgrade from emergency-use authorizations could open the door to vaccine mandates from more employers -- including the U.S. military -- and schools \n</p>\n<p>\n  The \"full\" approval of Pfizer's and Moderna's COVID-19 vaccines will almost certainly boost sagging vaccination rates in the U.S., though the Food and Drug Administration's decision might not come until the end of the year. \n</p>\n<p>\n  The Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and Moderna Inc. <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> vaccines, along with Johnson &amp; Johnson's <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> COVID-19 shot, have received emergency-use authorization, a less rigorous category of approval granted by the FDA that allowed the vaccines to be distributed more quickly during a critical stage of the public health emergency. \n</p>\n<p>\n  Though an FDA decision isn't required until the end of the year, people are already evaluating how a formal approval would impact lagging vaccination rates in the U.S. amid a murky landscape for required immunization in the U.S. \n</p>\n<p>\n  More than 153 million people in the U.S., or roughly 46% of the total population, have voluntarily chosen to get vaccinated, according to data  from the Centers for Disease Control and Prevention. \n</p>\n<p>\n  But a recent slowdown  \n</p>\n<p>\n  All signs point to a boost, whatever its magnitude, in the ongoing COVID-19 vaccination campaign in the U.S. if and when the vaccines are formally approved. \n</p>\n<p>\n  Approval will allow drug manufacturers to advertise their vaccines and, in some cases, set their own prices. It may also mean that employers and schools will have an established legal precedent to require vaccination, and it could tip people in the wait-and-see category to get vaccinated once they know the vaccines have gone through a more rigorous regulatory screening. \n</p>\n<p>\n  \"A third of people who are unvaccinated said that they'd be more likely to get the vaccine if ... <a href=\"https://laohu8.com/S/AONE\">one</a> of the vaccines received full approval from the FDA,\" said Liz Hamel, director of public opinion and survey research at the Henry J. Kaiser Family Foundation, which has studied COVID-19 vaccine hesitancy. \n</p>\n<p>\n  A full FDA approval could help the lagging vaccination rate in the U.S. \n</p>\n<p>\n  About 12% of unvaccinated people in the U.S. are part of the wait-and-see group, according to the Kaiser Family Foundation. They tend to be young adults and Black adults. \n</p>\n<p>\n  For some people, approval sounds safer than emergency authorization. \"We hear people say, it's just experimental at this point. It's not approved yet,\" Hamel said. \"They hear terms like 'emergency,' and then they are just still cautious.\" \n</p>\n<p>\n  Arkansas Gov. Asa Hutchinson said the state needs full approval to combat vaccine hesitancy. \"It was approved as emergency use,\" the Republican told \"Face the Nation\"  this weekend. \"And so, for that reason, you can't mandate it.\" \n</p>\n<p>\n  An FDA approval for a COVID-19 vaccine requires six months of follow-up data from the clinical trial, three times the two months' worth of follow-up data  used to inform emergency authorization. \n</p>\n<p>\n  The regulator has 60 days after the companies submit their applications to decide if it is going to grant \"priority review,\" a designation that requires the federal agency to make a decision whether or not to approve the vaccine within six months. Pfizer said it submitted its application on May 7; Moderna followed, on June 1, with its submission. \n</p>\n<p>\n  Between 6% and 7% of unvaccinated Americans say they'll get a shot only if they are required by an employer or a school, or to travel. While some employers already require vaccinations -- the Houston Methodist hospital system in Texas went to legal lengths  for returning employees -- these kinds of requirements are not the norm. \n</p>\n<p>\n  The U.S. military, with its 1.3 million active-duty members, has not required vaccination but has suggested  he would leave that decision in the hands of the military brass. \n</p>\n<p>\n  \"Some people will respond to incentives, and some will respond to requirements,\" the Kaiser Family Foundation's Hamel said. \n</p>\n<p>\n  We'll see TV ads promoting vaccines. \n</p>\n<p>\n  Right now, drug companies are limited in what they are allowed to say about their vaccines based on the rules of emergency authorization. They can't advertise the vaccines to the public or to prescribers -- or proactively explain the safety and effectiveness of their shots. \n</p>\n<p>\n  \"You essentially have to stick to the script that's in the EUA,\" said Cody Powers, a COVID-19 vaccine expert at ZS, a pharmaceutical consulting firm. \"You can't make explicit claims about safety and effectiveness.\" \n</p>\n<p>\n  If and when FDA approvals are granted, companies like Moderna and Pfizer may stay cautious in their approach to marketing COVID-19 vaccines in the U.S. Traditionally, pharmaceutical companies hold off on putting out direct-to-consumer ads for six months after approval as a result of concerns about aggressive marketing practices. In this case, there likely will be worries about corporate profit motivations during a global pandemic. \n</p>\n<p>\n  \"If they feel like they're jeopardizing both their own perception and the success of overall inoculations in the U.S., they might step back,\" Powers said. \n</p>\n<p>\n  Drug manufacturers usually start with disease-awareness campaigns for new products and then later launch brand campaigns that seek to either raise awareness of their particular offering or to differentiate it. \n</p>\n<p>\n  But this moment in time is very different. The American public already knows about the vaccines and their makers. In fact, many people are well-versed in efficacy rates from the clinical trials and even how the FDA regulatory process works. That means we already have perceptions of each vaccine, whether that's sillier ones, like the TikTok idea that Pfizer's vaccine is for \"hot\" people . \n</p>\n<p>\n  \"When you can make claims about the vaccine, then all the promotional machinery around that claim turns on,\" Powers said. \"It's a really weird situation for most manufacturers, where they're actually having to make decisions about whether to just roll with what they've inherited or try to change people's perceptions.\" \n</p>\n<p>\n  The price of at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> vaccine may eventually go up. \n</p>\n<p>\n  Moderna will also gain more control over the pricing of its vaccine once it is approved, according to remarks made earlier this month by CEO Stéphane Bancel. \n</p>\n<p>\n  The price of Moderna's shot works out to $15 per dose, in comparison with the $19.50 charged by Pfizer , had more price-setting freedom. \n</p>\n<p>\n  With approval, \"we should be able to go into the private market,\" Moderna's Bancel told investors. \"The price is pretty low because at the time the deal was done there was no clinical data.\" -- Jaimy Lee \n</p>\n<p>\n  Colleges are going to lead the way when it comes to requiring vaccines in educational settings. \n</p>\n<p>\n  Hundreds of colleges  in the U.S. have announced vaccine requirements for students and, less often, employees. But full FDA approval is expected to broaden both the number of schools mandating vaccination and the scope of the requirements in place. \n</p>\n<p>\n  The California Institute of Technology said  everyone in its community to get vaccinated. \n</p>\n<p>\n  (MORE TO FOLLOW) Dow Jones Newswires\n</p>\n<p>\n  June 28, 2021 17:36 ET (21:36 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","JNJ":"强生"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147449837","content_text":"MW Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away\n\n\n  Jaimy LeeJillian BermanAndrew Keshner \n\n\n  Upgrade from emergency-use authorizations could open the door to vaccine mandates from more employers -- including the U.S. military -- and schools \n\n\n  The \"full\" approval of Pfizer's and Moderna's COVID-19 vaccines will almost certainly boost sagging vaccination rates in the U.S., though the Food and Drug Administration's decision might not come until the end of the year. \n\n\n  The Pfizer Inc. $(PFE)$ and Moderna Inc. $(MRNA)$ vaccines, along with Johnson & Johnson's $(JNJ)$ COVID-19 shot, have received emergency-use authorization, a less rigorous category of approval granted by the FDA that allowed the vaccines to be distributed more quickly during a critical stage of the public health emergency. \n\n\n  Though an FDA decision isn't required until the end of the year, people are already evaluating how a formal approval would impact lagging vaccination rates in the U.S. amid a murky landscape for required immunization in the U.S. \n\n\n  More than 153 million people in the U.S., or roughly 46% of the total population, have voluntarily chosen to get vaccinated, according to data  from the Centers for Disease Control and Prevention. \n\n\n  But a recent slowdown  \n\n\n  All signs point to a boost, whatever its magnitude, in the ongoing COVID-19 vaccination campaign in the U.S. if and when the vaccines are formally approved. \n\n\n  Approval will allow drug manufacturers to advertise their vaccines and, in some cases, set their own prices. It may also mean that employers and schools will have an established legal precedent to require vaccination, and it could tip people in the wait-and-see category to get vaccinated once they know the vaccines have gone through a more rigorous regulatory screening. \n\n\n  \"A third of people who are unvaccinated said that they'd be more likely to get the vaccine if ... one of the vaccines received full approval from the FDA,\" said Liz Hamel, director of public opinion and survey research at the Henry J. Kaiser Family Foundation, which has studied COVID-19 vaccine hesitancy. \n\n\n  A full FDA approval could help the lagging vaccination rate in the U.S. \n\n\n  About 12% of unvaccinated people in the U.S. are part of the wait-and-see group, according to the Kaiser Family Foundation. They tend to be young adults and Black adults. \n\n\n  For some people, approval sounds safer than emergency authorization. \"We hear people say, it's just experimental at this point. It's not approved yet,\" Hamel said. \"They hear terms like 'emergency,' and then they are just still cautious.\" \n\n\n  Arkansas Gov. Asa Hutchinson said the state needs full approval to combat vaccine hesitancy. \"It was approved as emergency use,\" the Republican told \"Face the Nation\"  this weekend. \"And so, for that reason, you can't mandate it.\" \n\n\n  An FDA approval for a COVID-19 vaccine requires six months of follow-up data from the clinical trial, three times the two months' worth of follow-up data  used to inform emergency authorization. \n\n\n  The regulator has 60 days after the companies submit their applications to decide if it is going to grant \"priority review,\" a designation that requires the federal agency to make a decision whether or not to approve the vaccine within six months. Pfizer said it submitted its application on May 7; Moderna followed, on June 1, with its submission. \n\n\n  Between 6% and 7% of unvaccinated Americans say they'll get a shot only if they are required by an employer or a school, or to travel. While some employers already require vaccinations -- the Houston Methodist hospital system in Texas went to legal lengths  for returning employees -- these kinds of requirements are not the norm. \n\n\n  The U.S. military, with its 1.3 million active-duty members, has not required vaccination but has suggested  he would leave that decision in the hands of the military brass. \n\n\n  \"Some people will respond to incentives, and some will respond to requirements,\" the Kaiser Family Foundation's Hamel said. \n\n\n  We'll see TV ads promoting vaccines. \n\n\n  Right now, drug companies are limited in what they are allowed to say about their vaccines based on the rules of emergency authorization. They can't advertise the vaccines to the public or to prescribers -- or proactively explain the safety and effectiveness of their shots. \n\n\n  \"You essentially have to stick to the script that's in the EUA,\" said Cody Powers, a COVID-19 vaccine expert at ZS, a pharmaceutical consulting firm. \"You can't make explicit claims about safety and effectiveness.\" \n\n\n  If and when FDA approvals are granted, companies like Moderna and Pfizer may stay cautious in their approach to marketing COVID-19 vaccines in the U.S. Traditionally, pharmaceutical companies hold off on putting out direct-to-consumer ads for six months after approval as a result of concerns about aggressive marketing practices. In this case, there likely will be worries about corporate profit motivations during a global pandemic. \n\n\n  \"If they feel like they're jeopardizing both their own perception and the success of overall inoculations in the U.S., they might step back,\" Powers said. \n\n\n  Drug manufacturers usually start with disease-awareness campaigns for new products and then later launch brand campaigns that seek to either raise awareness of their particular offering or to differentiate it. \n\n\n  But this moment in time is very different. The American public already knows about the vaccines and their makers. In fact, many people are well-versed in efficacy rates from the clinical trials and even how the FDA regulatory process works. That means we already have perceptions of each vaccine, whether that's sillier ones, like the TikTok idea that Pfizer's vaccine is for \"hot\" people . \n\n\n  \"When you can make claims about the vaccine, then all the promotional machinery around that claim turns on,\" Powers said. \"It's a really weird situation for most manufacturers, where they're actually having to make decisions about whether to just roll with what they've inherited or try to change people's perceptions.\" \n\n\n  The price of at least one vaccine may eventually go up. \n\n\n  Moderna will also gain more control over the pricing of its vaccine once it is approved, according to remarks made earlier this month by CEO Stéphane Bancel. \n\n\n  The price of Moderna's shot works out to $15 per dose, in comparison with the $19.50 charged by Pfizer , had more price-setting freedom. \n\n\n  With approval, \"we should be able to go into the private market,\" Moderna's Bancel told investors. \"The price is pretty low because at the time the deal was done there was no clinical data.\" -- Jaimy Lee \n\n\n  Colleges are going to lead the way when it comes to requiring vaccines in educational settings. \n\n\n  Hundreds of colleges  in the U.S. have announced vaccine requirements for students and, less often, employees. But full FDA approval is expected to broaden both the number of schools mandating vaccination and the scope of the requirements in place. \n\n\n  The California Institute of Technology said  everyone in its community to get vaccinated. \n\n\n  (MORE TO FOLLOW) Dow Jones Newswires\n\n\n  June 28, 2021 17:36 ET (21:36 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":267,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159340840,"gmtCreate":1624943653180,"gmtModify":1703848538431,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159340840","repostId":"2147858544","repostType":2,"repost":{"id":"2147858544","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624924843,"share":"https://ttm.financial/m/news/2147858544?lang=&edition=fundamental","pubTime":"2021-06-29 08:00","market":"us","language":"en","title":"UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light","url":"https://stock-news.laohu8.com/highlight/detail?id=2147858544","media":"Reuters","summary":"(Adds Wells Fargo details, executive quotes)   By David Henry and Niket  Nishant   June 28 (Reuters)","content":"<html><body><p>(Adds Wells Fargo details, executive quotes)</p><p>   By David Henry and Niket  Nishant</p><p>   June 28 (Reuters) - <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week. </p><p>   Analysts and investors had expected </p><p>the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.</p><p>   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents. </p><p>   The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.</p><p>   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"</p><p>   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase &amp; Co    said it will go to $1.00 a share from 90 cents for the third quarter. </p><p>   Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25. </p><p>   Wells Fargo &amp; Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September. </p><p>   The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.</p><p>   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.</p><p>   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.</p><p>   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.</p><p>   CITIGROUP</p><p>   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%. </p><p>   A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.</p><p>   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.</p><p>   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.</p><p>   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.</p><p>   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules.</p><p> (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)</p><p>((Niket.Nishant@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 08:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds Wells Fargo details, executive quotes)</p><p>   By David Henry and Niket  Nishant</p><p>   June 28 (Reuters) - <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week. </p><p>   Analysts and investors had expected </p><p>the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.</p><p>   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents. </p><p>   The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.</p><p>   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"</p><p>   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase &amp; Co    said it will go to $1.00 a share from 90 cents for the third quarter. </p><p>   Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25. </p><p>   Wells Fargo &amp; Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September. </p><p>   The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.</p><p>   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.</p><p>   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.</p><p>   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.</p><p>   CITIGROUP</p><p>   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%. </p><p>   A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.</p><p>   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.</p><p>   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.</p><p>   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.</p><p>   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules.</p><p> (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)</p><p>((Niket.Nishant@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛","JPM":"摩根大通","WFC":"富国银行","MS":"摩根士丹利","C":"花旗","BAC":"美国银行"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147858544","content_text":"(Adds Wells Fargo details, executive quotes)   By David Henry and Niket  Nishant   June 28 (Reuters) - Morgan Stanley, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week.    Analysts and investors had expected the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents.    The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase & Co    said it will go to $1.00 a share from 90 cents for the third quarter.    Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25.    Wells Fargo & Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September.    The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.   CITIGROUP   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%.    A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules. (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)((Niket.Nishant@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159357544,"gmtCreate":1624943630288,"gmtModify":1703848536653,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159357544","repostId":"2147858544","repostType":2,"repost":{"id":"2147858544","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624924843,"share":"https://ttm.financial/m/news/2147858544?lang=&edition=fundamental","pubTime":"2021-06-29 08:00","market":"us","language":"en","title":"UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light","url":"https://stock-news.laohu8.com/highlight/detail?id=2147858544","media":"Reuters","summary":"(Adds Wells Fargo details, executive quotes)   By David Henry and Niket  Nishant   June 28 (Reuters)","content":"<html><body><p>(Adds Wells Fargo details, executive quotes)</p><p>   By David Henry and Niket  Nishant</p><p>   June 28 (Reuters) - <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week. </p><p>   Analysts and investors had expected </p><p>the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.</p><p>   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents. </p><p>   The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.</p><p>   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"</p><p>   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase &amp; Co    said it will go to $1.00 a share from 90 cents for the third quarter. </p><p>   Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25. </p><p>   Wells Fargo &amp; Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September. </p><p>   The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.</p><p>   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.</p><p>   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.</p><p>   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.</p><p>   CITIGROUP</p><p>   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%. </p><p>   A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.</p><p>   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.</p><p>   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.</p><p>   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.</p><p>   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules.</p><p> (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)</p><p>((Niket.Nishant@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 3-Wall Street banks hike shareholder payouts after Fed gives the green light\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-29 08:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds Wells Fargo details, executive quotes)</p><p>   By David Henry and Niket  Nishant</p><p>   June 28 (Reuters) - <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week. </p><p>   Analysts and investors had expected </p><p>the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.</p><p>   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents. </p><p>   The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.</p><p>   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"</p><p>   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase &amp; Co    said it will go to $1.00 a share from 90 cents for the third quarter. </p><p>   Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25. </p><p>   Wells Fargo &amp; Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September. </p><p>   The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.</p><p>   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.</p><p>   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.</p><p>   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.</p><p>   CITIGROUP</p><p>   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%. </p><p>   A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.</p><p>   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.</p><p>   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.</p><p>   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.</p><p>   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules.</p><p> (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)</p><p>((Niket.Nishant@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛","JPM":"摩根大通","WFC":"富国银行","MS":"摩根士丹利","C":"花旗","BAC":"美国银行"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147858544","content_text":"(Adds Wells Fargo details, executive quotes)   By David Henry and Niket  Nishant   June 28 (Reuters) - Morgan Stanley, JPMorgan, Bank of America, Goldman Sachs and Wells Fargo said on Monday they were hiking their capital payouts after the U.S. Federal Reserve gave them a clean bill of health following their annual \"stress tests\" last week.    Analysts and investors had expected the country's largest lenders to start issuing as much as $130 billion in dividends and stock buybacks from next month after the Fed last week ended emergency pandemic-era restrictions on how much capital they could give back to investors.   Morgan Stanley    delivered the biggest surprise to investors, however, saying it would double its dividend to 70 cents a share in the third quarter of 2021. Some analysts had been expecting a boost to about 50 cents.    The Wall Street giant also said it would increase spending on share repurchases. Its shares rose as much as 3.7% in after-market trading following the announcement.   Morgan Stanley CEO James Gorman said in the announcement that the bank could return so much capital because of the excess it has accumulated over several years. The action, he said, \"reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.\"   $Bank of America Corp(BAC-N)$    said it will hike its dividend by 17% to 21 cents a share beginning in the third quarter of 2021, and JPMorgan Chase & Co    said it will go to $1.00 a share from 90 cents for the third quarter.    Goldman Sachs Group    said it planned to increase its common stock dividend to $2 per share from $1.25.    Wells Fargo & Co   , which has built up capital more rapidly than rivals due in part to a Fed-imposed cap on its balance sheet, said it plans to repurchase $18 billion of stock over the four quarters beginning in September.    The repurchase target amounts to nearly 10% of its stock market value and is line with expectations from analysts.   Wells Fargo, which for years has been trying to move past a series of costly mis-selling scandals, said it was doubling its quarterly dividend to 20 cents a share, consistent with analyst expectations.   \"Since the COVID-19 pandemic began, we have built our financial strength ... as well as continuing to remediate our legacy issues,\" CEO Charlie Scharf said in a statement.   \"We will continue to do so as we return a significant amount of capital to our shareholders,\" Scharf added.   CITIGROUP   Citigroup   , meanwhile, confirmed analysts' estimates that a key part of its required capital ratios had increased under the stress test results to 3.0% from 2.5%.    A hike of that size will limit Citigroup's share buybacks, versus its peers, a report from analyst Vivek Juneja of JPMorgan shows. Juneja expects Citigroup will have the lowest capital return of big banks he covers.   Citigroup CEO Jane Fraser said the bank will continue its \"planned capital actions, including common dividends of at least $0.51 per share\" and buying back shares in the market.   Bank of America's shares were flat in after hours trading, Goldman Sachs' shares were up 0.6%, while Citigroup's and JPMorgan's were down 0.9% and 0.3% respectively.   The Fed said on Thursday it was ending its remaining curbs on dividend payouts after finding the country's largest banks would remain well capitalized in its latest stress tests.   The central bank said the test found 23 of the largest firms would suffer a combined $474 billion in losses under a hypothetical severe downturn, but would still have more than twice as much capital required under Fed rules. (Reporting by Niket Nishant in Bengaluru and David Henry in New York; additional reporting by Anirban Sen and Noor Zainab Hussain; writing by Michelle Price; Editing by Sriraj Kalluvila, Dan Grebler and Himani Sarkar)((Niket.Nishant@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183259961,"gmtCreate":1623333572453,"gmtModify":1704201146262,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183259961","repostId":"1185996577","repostType":4,"repost":{"id":"1185996577","pubTimestamp":1623328186,"share":"https://ttm.financial/m/news/1185996577?lang=&edition=fundamental","pubTime":"2021-06-10 20:29","market":"us","language":"en","title":"Baird says GameStop's turnaround plan remains a mystery, predicts 90% stock decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1185996577","media":"cnbc","summary":"The plan to turn beleaguered retailerGameStopinto an e-commerce powerhouse is still murky five month","content":"<div>\n<p>The plan to turn beleaguered retailerGameStopinto an e-commerce powerhouse is still murky five months after the stock first caught fire, according to investment firm Baird.\nOn Wednesday, the company ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/baird-says-gamestops-turnaround-plan-remains-a-mystery-predicts-90percent-stock-decline.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baird says GameStop's turnaround plan remains a mystery, predicts 90% stock decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaird says GameStop's turnaround plan remains a mystery, predicts 90% stock decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 20:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/10/baird-says-gamestops-turnaround-plan-remains-a-mystery-predicts-90percent-stock-decline.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The plan to turn beleaguered retailerGameStopinto an e-commerce powerhouse is still murky five months after the stock first caught fire, according to investment firm Baird.\nOn Wednesday, the company ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/10/baird-says-gamestops-turnaround-plan-remains-a-mystery-predicts-90percent-stock-decline.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://www.cnbc.com/2021/06/10/baird-says-gamestops-turnaround-plan-remains-a-mystery-predicts-90percent-stock-decline.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1185996577","content_text":"The plan to turn beleaguered retailerGameStopinto an e-commerce powerhouse is still murky five months after the stock first caught fire, according to investment firm Baird.\nOn Wednesday, the company reported stronger-than-expected revenues for thefirst quarter, helped by console sales, and announced that it had tapped twoAmazon veterans for roles as CEO and CFO. They join board member and Chewy co-founder Ryan Cohen as high-level leaders at the company with e-commerce experience.\nHowever, the company declined to provide forward guidance and announced that it might sell up to 5 million shares. The stock was down in premarket trading Thursday.\nBaird analyst Colin Sebastian reiterated his neutral rating on the stock after the earnings report, saying that the eventual turnaround for the company plan remained unclear.\n“As GameStop’s board continues to shuffle the management deck, the goal to transform into a ‘technology’ company that delights gamers remains mostly a mystery, particularly as the video game industry accelerates the shift toward downloads, streaming and cloud services,” the note said. “No doubt the console transition period is providing a lifeline, but games are not dog food, and investors deserve more than memes to value a company’s fundamental, long-term prospects.”\nBaird has a price target of $25 per share for GameStop, more than 90% below where the stock closed on Wednesday.\nThe firm raised its estimates for the second quarter, but said that the recent boost from console sales wouldn’t last forever.\n“We are increasing our Q2 revenue and EPS estimates to reflect the favorable impact of easing console supply constraints; however, we are also slightly lowering our Q3 and Q4 estimates as some hardware demand will likely be pulled forward as availability improves faster than previously expected,” the note said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180946612,"gmtCreate":1623172741636,"gmtModify":1704197712201,"author":{"id":"3581648312409141","authorId":"3581648312409141","authorIdStr":"3581648312409141","name":"Louisssss","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581648312409141"},"themes":[],"htmlText":"Good buy","listText":"Good buy","text":"Good buy","images":[{"img":"https://static.tigerbbs.com/a6d400477c6dd932602dbc8dbbe1525a","width":"720","height":"1316"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180946612","isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}